Alcoholic Liver Disease - Epidemiology

Relevant Publications

The Association Between Neutrophil/High-Density Lipoprotein Cholesterol Ratio and Non-Alcoholic Fatty Liver Disease in a Healthy Population.

Issue Release: 2024

Lipoprotein Combine Index as a Better Marker for NAFLD Identification Than Traditional Lipid Parameters.

Issue Release: 2024

Evaluation of the role of some non-enzymatic antioxidants among Iraqi patients with non-alcoholic fatty liver disease.

Issue Release: 2024

The role and mechanism of SUMO modification in liver disease.

Issue Release: 2024

Xiezhuo Tiaozhi formula inhibits macrophage pyroptosis in the non-alcoholic fatty liver disease by targeting the SIRT1 pathway.

Issue Release: 2024

Diet, lifestyle factors, comorbidities, and hepatocellular carcinoma risk in a middle eastern country: a case-control study.

Issue Release: 2024

Efficacy and safety of Qushi Huayu, a traditional Chinese medicine, in patients with nonalcoholic fatty liver disease in a randomized controlled trial.

Issue Release: 2024

Therapeutic potential of Phycocyanin in gastrointestinal cancers and related disorders.

Issue Release: 2024

Pediatric metabolic (dysfunction)-associated fatty liver disease: current insights and future perspectives.

Issue Release: 2024

Comparative genomic and metabolomic analysis reveals the potential of a newly isolated Enterococcus faecium B6 involved in lipogenic effects.

Issue Release: 2024

A Protein Complex of Liver Origin Activates a Pro-inflammatory Program That Drives Hepatic and Intestinal Injury in Alcohol-Associated Liver Disease.

Issue Release: 2024

Association between the cardiometabolic index and NAFLD and fibrosis.

Issue Release: 2024

An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD).

Issue Release: 2024

Impact of lifestyle interventions on pathogenesis of nonalcoholic fatty liver disease.

Issue Release: 2024

Comparative study of MAFLD as a predictor of metabolic disease treatment for NAFLD.

Issue Release: 2024

Benzorhodol derived far-red/near-infrared fluorescent probes for selective and sensitive detection of butyrylcholinesterase activity in living cells and the non-alcoholic fatty liver of zebrafish.

Issue Release: 2024

Mast cells and the gut-liver Axis: Implications for liver disease progression and therapy.

Issue Release: 2024

Alantolactone attenuates high-fat diet-induced inflammation and oxidative stress in non-alcoholic fatty liver disease.

Issue Release: 2024

Integrated bioinformatics and multiomics reveal Liupao tea extract alleviating NAFLD via regulating hepatic lipid metabolism and gut microbiota.

Issue Release: 2024

Detection of early-stage NASH using non-invasive hyperpolarized C metabolic imaging.

Issue Release: 2024

What Technologies are Used in Genetic Sequencing?

How Do Imaging Techniques Aid in Disease Surveillance?

What is Case Fatality Rate (CFR)?

Why is Recalibration Important?

How Can Lung Function Data Inform Public Health Policy?

Why Are Guidelines Necessary?

What are the Criteria for a Good Hypothesis?

Why Focus on Minority Class?

What Are the Ethical Considerations in Genetic Epidemiology?

What is Fever?

Partnered Content Networks

Relevant Topics